More or less, RECQL1 expression was observed for all histological subtypes of OC, which may suggest an efficacy of RECQL1-siRNA on platinum-resistant cancers, such as clear cell adenocarcinoma, mucinous adenocarcinoma and some of recurrent cancers with platinum-resistant type. This evidence concerns the gene RECQL and clear cell adenocarcinoma.